|
WCOG Post Graduate Course |
|
|
Time (IST) |
Topics |
|
08:45 - 09:00 |
Welcome - Course Co-Chairs: |
|
09:00 - 10:00 |
Session: |
|
09:00 - 09:15 |
Managing GI Bleeding on Antiplatelets & Anticoagulants |
|
09:15 - 09:30 |
Topical Hemostatic Agents: How To Choose Between Powders, Gels & Sealants |
|
09:30 - 09:45 |
GI Bleeding In The Intensive Care Unit |
|
09:45 - 10:00 |
Q&A |
|
10:00 - 11:00 |
Session: |
|
10:00 - 10:15 |
Holistic Management of Metabolic Dysfunction-Associated Steatotic Liver Disease |
|
10:15 - 10:30 |
Chronic Hepatitis B Virus (HBV): New Targets and Drugs |
|
10:30 - 10:45 |
Diagnosis and Management of Hepatocellular Carcinoma in 2026 |
|
10:45 - 11:00 |
Q&A |
|
11:00 - 11:30 |
Nutrition Break |
|
11:30 - 12:30 |
Session: |
|
11:30 - 11:45 |
What is New in Rome V |
|
11:45 - 12:00 |
Pharmacological & Non-Pharmacological Treatment of Functional Dyspepsia |
|
12:00 - 12:15 |
Post-Infectious Irritable Bowel Syndrome (PI- IBS): Epidemiology, Diagnosis & Treatment |
|
12:15 - 12:30 |
Q&A |
|
12:30 - 13:30 |
Session: |
|
12:30 - 12:45 |
Acute Severe Ulcerative Colitis: Saving the Colon With Timely Interventions |
|
12:45 - 13:00 |
Approach to Refractory IBD |
|
13:00 - 13:15 |
The Role of Endoscopy in IBD |
|
13:15 - 13:30 |
Q&A |
|
13:30 - 14:30 |
Lunch |
|
14:30 - 15:30 |
Session: |
|
14:30 - 14:45 |
Autoimmune Pancreatitis (Type 1, 2, 3): Dilemmas in Diagnosis and Management |
|
14:45 - 15:00 |
Hypertriglyceridemia Associated Acute Pancreatitis: Outcomes and Preventive Strategies |
|
15:00 - 15:15 |
Pancreatic Cancer - Surveillance and Early Detection |
|
15:15 - 15:30 |
Q&A |
|
15:30 - 16:30 |
Session: |
|
15:30 - 15:45 |
Acute Liver Failure (ALF): Current Management Strategies |
|
15:45 - 16:00 |
Acute-on-Chronic Liver Failure (ACLF): Prognosis and Management |
|
16:00 - 16:15 |
Advances and Challenges in Liver Transplantation |
|
16:15 - 16:30 |
Q&A |
|
16:30 - 17:00 |
Nutrition Break |
|
17:00 - 18:00 |
Session: |
|
17:00 - 17:15 |
Celiac Disease: Current and Emerging Tests for Diagnosis |
|
17:15 - 17:30 |
Small Intestinal Bacterial Overgrowth (SIBO) and Non-Celiac Enteropathies |
|
17:30 - 17:45 |
Cascade Approach to Chronic Diarrhea: WGO Guidelines |
|
17:45 - 18:00 |
Q&A |
|
18:00 |
Closing Remarks - Course Co-Chairs |
|
19:00 - 20:00 |
Inauguration |
|
20:00 Onwards |
Welcome Dinner |
|
WCOG 2026 Scientific
Program |
|||||||
|
Time (IST) |
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
|
08:00 - 09:00 |
Video Digest |
Breakfast Session 1 |
Breakfast Session 2 |
Breakfast Session 3 |
Breakfast Session
|
Breakfast Session
|
Breakfast Session
|
|
09:00 - 10:00 |
Welcome and Orations |
|
|||||
|
Introductions |
|||||||
|
ISG - Presidential
Oration |
|||||||
|
WGO - Henry L. Bockus
Lecture |
|||||||
|
ISG - CM Habibullah Oration
|
|||||||
|
10:00 - 11:00 |
Session: |
||||||
|
10:00 - 10:15 |
Global Burden of GI and Liver
Diseases |
||||||
|
10:15 - 10:30 |
Epidemiology of Digestive
Cancer |
||||||
|
10:30 - 10:45 |
What Can Be Done to Change
The Trends: Awareness, Education, Public Policy |
||||||
|
10:45 - 11:00 |
Q&A / Panel Discussion |
||||||
|
11:00 - 11:15 |
Nutrition Break |
||||||
|
11:15 - 12:15 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
11:15 - 11:30 |
How to Perform a Standardized
Upper GI Endoscopy |
Functional Dyspepsia or
Gastroparesis |
Pathophysiology of MASLD:
Dissecting the Metabolic Dysfunction |
Understanding Pathophysiology
of AP: How the Evidence Evolved |
IBD's Global Footprint:
Where Are We Now? |
The Climate Change
Crisis |
|
|
11:30 - 11:45 |
Quality Indicators in
Colonoscopy: What Really Matters |
Choosing and Interpreting the
Investigations |
Screening and Risk
Stratification in MASLD |
From Acinar Injury to Organ
Dysfunction: How Does it Happen in Humans? |
Modifiying the Milieu:
Enviromental Triggers You Can Control |
Impact of Climate Change on
Vulnerable Populations |
|
|
11:45 - 12:00 |
ERCP Quality
Matrix |
Pharmacological and
Non-Pharmacological Treatment |
Pharmacotherapy in MASLD: How
to Choose a Drug? |
Revisiting the Severity
Classification of the Revised Atlanta Classification |
Eating for Remission:
Evidence-Based Dietary Protocols in Practice |
Approaches to Greening
Endoscopy |
|
|
12:00 - 12:15 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
|
|
12:15 - 13:15 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
12:15 - 12:30 |
Colorectal Cancer Screening:
Strategies in Resource Limited Settings |
Esophageal Ambulatory
pH-Impedancemetry |
Hepatitis A and E: Current
Situation and New Developments |
COX 2 Inhibitors in
AP |
Starting Strong: The
First-Line Advanced Therapy Choice in UC |
State of the Art: Microbiome
and Gut Health |
|
|
12:30 - 12:45 |
Risk Assessment of Polyps and
Colorectal Cancer |
Laryngo-Pharyngeal
Reflux |
Hepatitis B Treatment
Guidelines – How Best to Use Them in Daily Practice in Varied Resourced Settings
|
Pancreatitis Associated with
Systemic Diseases |
Bio-Naive vs Bio Experienced
Patient with Moderate to Severe CD: A Differential Strategy |
||
|
12:45 - 13:00 |
Emerging Non-invasive
Biomarkers for Colorectal Cancer Screening |
Treatment with Acid
Suppression Including PCABs |
Challenges in the Global
Elimination of Hepatitis C Virus |
Can We Prevent Pancreatic
Necrosis and Vascular Complications in AP |
The Era of Dual Therapy: Is
Two Better Than One? |
State of the Art:
Helicobacter Pylori Eradication Therapy to Prevent Gastric Cancer |
|
|
13:00 - 13:15 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
13:15 - 14:45 |
Lunch and Poster Viewing |
||||||
|
Industry Lunch |
Industry Lunch |
Industry Lunch |
Lunch Session |
Lunch Session |
Lunch Session |
||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
14:45 - 15:45 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
14:45 - 15:00 |
Indeterminate Biliary
Stricture: Current Standards & New Tools |
Investigations |
Non-Invasive Tests for MetALD
and Alcohol Related Liver Disease |
Optimizing Fluid Management:
Approaches Within and After 48 Hours |
Healing the Hidden: A
Multidisciplinary Approach to Fistulizing Disease Panelists: Francis Farraye, Jonathan Leighton, Ooi Choon Jin, Bhaskar Kante, David Mathew |
Adult
Education |
|
|
15:00 - 15:15 |
Management of Malignant Hilar
Obstruction |
Pharmacological and
Non-Pharmacological Treatment |
Next-Gen Therapies for
Alcoholic Hepatitis: Regeneration, Barrier Repair and Precision Immunology |
Managing Pain in
AP |
Providing Effective
Feedback |
||
|
15:15 - 15:30 |
ERCP In Altered Anatomy:
Strategy & Troubleshooting |
Global Guidelines |
Liver Transplantion in
Alcohol Related Liver Disease |
International Association of
Pancreatology Guidelines on Management of AP |
Pouch Preservation: Managing
the Refractory Patient Panelists: Francis Farraye, Jonathan Leighton, Ooi Choon Jin, Peeyush Kumar, Mridul Mahajan |
Presentation
Skills |
|
|
15:30 - 15:45 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
15:45 - 16:45 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
15:45 - 16:00 |
Gastric Varices: Best
Practices in 2026 |
Neuropsychological Issues in
DGBI |
Management of Non-Responders
to First Line Treatment in Autoimmune Hepatitis |
Diagnosis of Infected
Pancreatic Necrosis |
The Surgeon's Edge:
Timing is Everything |
Small Group
Facilitation |
|
|
16:00 - 16:15 |
Liver Biopsy: EUS vs
Percutaneous vs Transjugular |
Chronic Intestinal
Pseudo-Obstruction |
New Therapies for Primary
Biliary Cholangitis |
Current Therapeutic
Strategies to Manage Infected Necrotizing Pancreatitis |
The Second Act: Preventing
the Return of Crohn's |
Bedside
Teaching |
|
|
16:15 - 16:30 |
EUS-Guided Portal Vein Access
& Emerging Applications |
Approach to Fecal
Incontinence |
Future Treatment Options for
Primary Sclerosing Cholangitis |
Impact and Treatment of MDR
XDR Infection in Acute Necrotizing Pancreatitis |
The Crohn's Stricture
Toolkit: Balancing Medical, Endoscopic And Surgical Intervention |
Teaching a
Skill |
|
|
16:30 - 16:45 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
|
|
16:45 - 17:00 |
Nutrition Break |
||||||
|
17:00 - 18:00 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
17:00 - 17:15 |
Endoscopic Closure of Leaks
& Fistulae: Clips to Suturing - A Stepwise Approach |
Overlap Disorders of
Gut-Brain Interaction |
Novel Biomarkers and Pathways
in DILI: From Mechanistic Insights to Clinical Translation |
Psychological / Behavioural
Issues and Their Management in Chronic Pancreatitis |
Colorectal Surveillance in
IBD : Who, When and How? |
||
|
17:15 - 17:30 |
Regenerative Endoscopy &
Tissue Healing Strategies |
CAM- DILI - Regulate or
Prohibit? Public Health Impact, Evidence Gaps, and Medico-Legal Challenges
|
Fatty Pancreas: Summary of an
International Multidisciplinary Consensus |
Preventing Vascular and
Hematologic Complications |
|||
|
17:30 - 17:45 |
EndoVAC Therapy: Indications,
Technique & Optimization |
Achalasia and
POEM |
Immune-Mediated Liver Injury
from Check-Point Inhibitors (ILICI) |
Genetics of Recurrent Acute
and Chronic Pancreatitis: Guidance for Clinicians |
Uninvited Guests: Identifying
and Managing Opportunistic Infections in IBD |
||
|
17:45 - 18:00 |
Q&A |
Q&A |
Q&A |
Q&A |
|||
|
18:00 - 19:00 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
18:00 - 18:10 |
Correlation of ileocolonic
wall thickening detected on contrast enhanced computed tomography of abdomen with
ileocolonoscopy in patients presenting with gastrointestinal or systemic symptoms (Abstract
ID: 108) |
Serial serum interleukin-8
trajectories are associated with progression from Helicobacter pylori–associated
precancerous lesions to gastric cancer: A prospective longitudinal cohort study (Abstract
ID: 24) |
Mitochondrial Dysfunction
Drives Defective Macrophage Efferocytosis in Acute-on-Chronic
Liver Failure
(Abstract ID: 375) |
Beyond Diagnosis: Admission
Lipase Predicts Persistent Organ Failure in Hypertriglyceridemia-Associated Acute
Pancreatitis (Abstract ID: 849) |
Gut microbial production of
lithocholic acid reprograms pro-resolutive macrophages to enhance vedolizumab responsiveness
via the TGR5/FXR-NF-κB axis (Abstract ID: 103) |
||
|
18:10 - 18:20 |
Optimal Rectal Indomethacin
Dosage for Post-ERCP Pancreatitis Prevention in
First-Time Patients: A Randomized Controlled Trial (Abstract ID: 425) |
Clinicopathological and
Survival Correlation of Immunohistochemistry and In-Situ Hybridisation-Based Molecular
Classification of Gastric Cancer (Abstract ID: 100) |
Real-world performance of
large language models against multidisciplinary team decisions for hepatocellular carcinoma
(Abstract ID: 392)
|
A Distinct High-risk Subgroup
of Complicated Acute Necrotizing Pancreatitis Qualify as Severe Pancreatitis: A Dual-Centre
Study of 1383 Patients (Abstract ID: 1086) |
Butyrate Alleviates Crohn's
disease Intestinal Inflammation by Inhibiting the cGAS-STING-NLRP3 Axis-Mediated IECs
Pyroptosis (Abstract ID: 104)
|
||
|
18:20 - 18:30 |
Endoscopic Findings in
Uninvestigated Dyspepsia With or Without Alarming Symptoms: Should All Patients Referred to
a Gastroenterologist Undergo Upper Gastrointestinal Endoscopy? (Abstract ID:
489) |
Diagnostic Performance Of A
Tegoprazan Based Therapeutic Trial In Patients With Suspected Gerd: Interim Analysis Of The
Prospective Multicenter Phase Iv Tego-Test Study. (Abstract ID: 247)
|
Apixaban prevents hepatic
decompensations in patients with cirrhosis (ApiHep): A randomised controlled trial (Abstract
ID: 959)
|
Whole Genome Sequencing
Unravels The Transmission Landscape Of Pathogenic Bacteria From The Gut And Oral Cavity To
Infected Pancreatic Necrosis Pancreatitis (Abstract ID: 1090)
|
Efficacy and Tolerability of
Amitriptyline in Mild-to-moderate Ulcerative Colitis: A Double-blind Randomized Placebo
Controlled Trial (Abstract ID: 1037)
|
||
|
18:30 - 18:40 |
Towards an Ingestible
Pill-like Microdevice for Non-invasive Sampling of the Microbiome and Biomolecules in the
Upper GI Tract (Abstract ID: 564) |
Indian Ethnicity-Specific
Multi-Omic Landscape of Colorectal Cancer: Novel Signatures, Drivers, and Therapeutic
Targets (Abstract ID: 1016) |
"STING protein is associated
with an immune-cold hepatocellular carcinoma phenotype independent
of disease etiology (Abstract ID: 1014)"
|
Population-based Estimates of
the Prevalence and Risk Factors of Chronic Pancreatitis in India: a Nationwide Prospective
Study (Abstract ID: 1118)
|
Efficacy of a Plant-Based
Diet for Maintaining Remission in Ulcerative Colitis and Its Impact on Gut Microbiome
Restructuring: A 12-Month Randomised Controlled Trial (Abstract ID: 1060)
|
||
|
18:40 - 18:50 |
A Prospective Multi-Centric
study on efficacy and safety of yoga-based bowel preparation in colonoscopy (Abstract ID:
628)
|
Novel protein-based
non-invasive biomarkers for predicting enteropathy in patients with Celiac Disease (Abstract
ID: 1020)
|
Genomic Profiling of MASLD in
India: Discovery of Susceptibility Variants and Functional Insights for Precision Risk
Stratification (Abstract ID: 1068)
|
Beyond Transmural Drainage:
The Role of ERCP in Defining Pancreatic Duct Anatomy After Endoscopic Drainage of Pancreatic
Fluid Collections (Abstract ID: 1121)
|
"Unique gut microbiome
profile can distinguish Newly Diagnosed Treatment naive Intestinal Tuberculosis and Crohn`s
Disease: An Indian patient cohort study
(Abstract ID: 1061)"
|
||
|
18:50 - 19:00 |
Role of Endoscopy in the
Management of Complicated Forms of Hepatic Hydatid Cyst (Abstract ID: 911)
|
Ex-vivo enteroid model reveal
distinct epithelial regeneration deficits and DNA damage signatures in untreated and
gluten-free diet non-responsive celiac disease patients. (Abstract ID: 1021)
|
Effect of Probiotic Therapy
on Frailty in Patients with Decompensated Cirrhosis: A Randomized Controlled Trial (Abstract
ID: 1107)
|
Bile Mycobiome
Phosphoproteomic and Acetylomic Signatures Reveal Functional Drivers of Gallbladder
Carcinoma (Abstract ID: 1140)
|
Screening and validation of
OASL as a protein biomarker for differential diagnosis of ileocecal ulcers (Abstract ID:
1097)
|
||
|
19:00 |
Adjourn |
||||||
|
19:00 Onwards |
Networking & Banquet Dinner |
||||||
|
WCOG 2026 Scientific
Program |
|||||||
|
Time (IST) |
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
|
08:00 - 09:00 |
Gastroenterology Clinic |
Breakfast Session 4 |
Liver Basic Science Workshop |
Breakfast Session 5 |
Breakfast
Session |
Breakfast Session
|
Breakfast Session
|
|
08:00 - 08:15 |
|||||||
|
08:16 - 08:30 |
|||||||
|
08:30 - 08:45 |
|||||||
|
08:45 - 09:00 |
|||||||
|
09:00 - 10:00 |
Orations |
||||||
|
09:00 - 09:15 |
Introductions |
||||||
|
09:15 - 09:30 |
WGO - George Brohee
Lecture |
||||||
|
09:30 - 09:45 |
INASL - Presidential
Oration |
||||||
|
09:45 - 10:00 |
INASL - Dr DV Datta Memorial
Oration |
||||||
|
09:45 - 10:00 |
Oration by Nobel Laureate |
||||||
|
|
The greatest Obstacle to Discovery: The Ilussion of KnowledgeBarry Marshall, Australia |
||||||
|
10:30 - 11:00 |
Panel Discussion |
||||||
|
11:00 - 11:15 |
Nutrition Break |
||||||
|
11:15 - 12:15 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
11:15 - 11:30 |
Introductions
|
Global Epidemiology of H.
Pyori Infections and Implications for Public Health |
Difficult CBD Stones: Modern
Endoscopic Solutions |
Redefining IBD Monitoring
With Ultrasound |
Early Chronic Pancreatitis:
Is The Process Reversible? |
What are the Barriers For a
Female Gastroenterologist and How We Can Change Them? |
|
|
11:30 - 11:45 |
INASL - Dr SR Naik Memorial
Oration |
Diagnosis of H. Pylori: When
and How Test for Hp |
Pre-Operative Biliary
Drainage: When & How |
Improving Clinical Decisions
with Modern Endoscopic Tools |
Dr. RK Tandon Oration -
"Chronic Pancreatitis and Precursors to Pancreatic Cancer: Pathogenesis and Clinical
Approaches to Early Cancer Detection" |
Gastroenterology Training:
Challenges and Opportunities For Women |
|
|
11:45 - 12:00 |
INASL - Dr BN Tandon Memorial
Oration |
Treatment of H. Pylori in
2026 |
Endoscopic Management of
PSC |
Artificial Intelligence in
IBD: Impact on Outcomes |
Advancing Into Leadership
Roles |
||
|
12:00 - 12:15 |
INASL - Dr N Madangopalan
Memorial Oration |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
|
|
12:15 - 13:15 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
12:15 - 12:30 |
Assessment of Clinically
Significant Portal Hypertension (CSPH) in 2026 |
Shifts in Gastric Cancer
Epidemiology and Its Implications Worldwide |
Best Techniques for
EUS-Guided Tissue Acquisition |
From Lab to Clinic:
Harnessing Microbiota for Healing |
Pancreatic Neuroendocrine
Tumours (NET) |
The Burden of Burnout in
Health Care |
|
|
12:30 - 12:45 |
Beyond Beta-Blockers:
Emerging Therapies and Anticoagulation Strategies |
Enhancing Detection of Early
Gastric Cancer in Resource Constrained Settings |
Approach to the Incidental
Pancreatic Cyst |
The Youngest Patients:
Unravelling VEO-IBD |
IPMN and Pancreatic Cystic
Neoplasms: Summary of Guidelines From Biology To Precision Surgery |
Strategies to Improve
Wellbeing |
|
|
12:45 - 13:00 |
Factors and Clinical Outcomes
in Cirrhosis Recompensation |
Diagnosis And Management of
Atrophic Gastritis And Intestinal Metaplasia |
EUS Approach to Gallbladder
Disorders |
Precision IBD: Transition
From One-Size-Fits-All to Patient-Centric Care |
Precision Medicine in
Pancreatic Cancer |
Communication Skills and
Difficult Conversation |
|
|
13:00 - 13:15 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
|
|
13:15 - 14:45 |
Lunch and Poster Viewing |
||||||
|
Industry Lunch
Symposium |
Industry Lunch
Symposium |
Industry Lunch
Symposium |
Lunch
Session |
Lunch Session |
Lunch Session |
||
|
14:45 - 15:45 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session |
Session: |
|
14:45 - 15:00 |
Treatment Options For
Refractory Ascites |
Global Epidemiology of Celiac
Disease And Future Projections |
More Than a Diagnosis: Living
Well with IBD |
Developing a Chemotherapeutic
Molecule for Pancreatic Cancer: Lessons From a Personal Journey |
|||
|
15:00 - 15:15 |
Long-Term Albumin For
Decompensated Cirrhosis |
Breaking Free: Treatments for
Celiac Disease Beyond Gluten-Free Diet |
Stopping The Spark: The
Future of IBD Prevention |
Multimodality Treatment of
Pancreatic Cancer – Where Are We Now |
|||
|
15:15 - 15:30 |
Current and Future Management
of HRS-AKI |
Increasing The Detection of
Celiac Disease Globally: Opportunities And Challenges |
Intercepting The Disease:
Strategies for Secondary Prevention |
Radiomics and AI in
Pancreatic Cancer |
|||
|
15:30 - 15:45 |
Q&A |
Q&A |
Q&A |
Q&A |
|||
|
15:45 - 16:45 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session |
Session: |
|
15:45 - 16:00 |
Pathophysiology of Hepatic
Encephalopathy: Beyond Ammonia |
Secretory Diarrhea: An
Investigative Approach |
Latest Guidelines for
Pregnancy and IBD |
Metabolic Red Flags: New
Onset Diabetes, Sarcopenia and Unexplained Weight Loss as Predictors |
|||
|
16:00 - 16:15 |
New Diagnostic Tools and
Biomarkers in Hepatic Encephalopathy |
Global Burden of GI Parasitic
Infection: Impact on Human Health in The 21st century |
CCFI Guidelines for IBD:
Sequencing Therapy Crohn Disease |
Prehabilitation Before
Surgery For Pancreatic Cancer |
|||
|
16:15 - 16:30 |
Minimal Hepatic
Encephalopathy: Treat or Not |
Hospital Acquired
Diarrhea |
Sequencing therapy Ulcerative
Colitis |
Surgery for Oligometastatic
Pancreatic Cancer |
|||
|
16:30 - 16:45 |
Q&A |
Q&A |
Q&A |
Q&A |
|
||
|
16:45 - 17:00 |
Nutrition Break |
||||||
|
|
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
17:00 - 17:15 |
New Strategies For
Surveillance For HCC in Cirrhosis |
Beyond Short Bowel Syndrome
|
Metabolic Endoscopy: Beyond
Weight Loss |
Discussant |
|||
|
17:15 - 17:30 |
Staging and Decision Making
For Treatment in HCC |
Assessment of Intestinal
Failure |
Endoscopic Gastric Remodeling
Techniques |
||||
|
17:30 - 17:45 |
Managing Unresectable HCC -
Emerging Options |
Short And Long Term Treatment
Options |
Role of GLP-1 Therapy in
Bariatric Endoscopy |
||||
|
17:45 - 18:00 |
Q&A |
Q&A |
Q&A |
||||
|
18:00 - 19:00 |
Session: |
Session: |
Session: |
Session: |
Session: Pancreas |
Session: |
|
|
18:00 - 18:15 |
Current and Emerging Concepts
in Diagnosis and Management of PSVD/NCPF |
Eating Disorders
|
Corrosive Strictures:
Endoscopic Strategies |
Increasing your changes of
Acceptance |
Calcium Signalling Within
Acinar Cells |
||
|
18:15 - 18:30 |
Management of Budd Chiari
Syndrome: Current Status and Dilemmas |
Impact of Ultra-Processed
Food |
Esophageal Stenting:
Indications & Techniques |
Introduction to Journal of
Clinical Gastroenterology - The WGO Official Journal |
Immunological Mechansisms of Progression in Chronic Pancreatitis |
||
|
18:30 - 18:45 |
Management of Portal Vein
Thrombosis is Cirrhosis |
FODMAP Diet for
DGBI |
Barrett's Esophagus:
Diagnosis and Management |
Use of AI in Research and
Publications ? |
Plasma Metabolite Signatures in Pancreartic Cancer: Differentiating From Chronic Pancreatitis |
||
|
18:45 - 19:00 |
Q&A |
Q&A |
Q&A |
Panel Discussion / Q&A |
|
||
|
19:00 - 20:00 |
Session: |
Industry
Dinner |
Session: |
Industry
Dinner |
Industry
Dinner |
Industry
Dinner |
Industry
Dinner |
|
19:00 - 19:15 |
Referral for Liver
Transplantation: When is it Too Early and Late? |
||||||
|
19:15 - 19:30 |
Immunosuppressive Strategies
in Liver Transplantation: Tricks of the Trade |
||||||
|
19:30 - 19:45 |
Liver Transplantation for
ACLF - Recent Concepts |
||||||
|
19:45 - 20:00 |
Panel Discussion / Q&A |
||||||
|
20:00 |
Adjourn |
||||||
|
20:30 Onwards |
Dinner |
||||||
|
WCOG 2026 Scientific
Program |
|||||||
|
Time (IST) |
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
|
08:00 - 09:00 |
Liver Clinico-Pathological Conference (CPC) |
Liver Clinico-Pathological Conference (CPC) |
Industry Breakfast Symposium
1 |
Industry Breakfast Symposium
2 |
Breakfast Session
|
Breakfast Session
|
Breakfast Session
|
|
08:00 - 08:20 |
Liver Clinico-Pathological
Conference (CPC) |
|
|||||
|
08:20 - 08:30 |
Discussion |
|
|||||
|
08:30 - 08:50 |
Pathology Discussant
(Speaker) |
|
|||||
|
08:50 - 09:00 |
Discussion |
|
|||||
|
09:00 - 10:00 |
Orations 5 |
||||||
|
09:00 - 09:15 |
Introduction |
||||||
|
09:15 - 09:30 |
IPC - Presidents
Oration |
||||||
|
09:30 - 09:45 |
ISG - PN Chuttani Oration "Global Burden of Celiac Disease: Opportunities and Challenges" Govind K Makharia, India |
||||||
|
09:45 - 10:00 |
ISG - Dr Rakesh Tandon
Oration
"Ultra-Processed Foods: Packaging to Pathology" |
||||||
|
10:00 - 11:00 |
Session:
|
||||||
|
10:00 - 10:10 |
Efficacy and safety of microfragmented autologous adipose tissue transplantation for perianal fistulas in Crohn’s disease (ATTIC): a phase 3 multicenter randomized controlled trial (Abstract ID: 162) |
||||||
|
10:10 - 10:20 |
Growth Hormone in Alcohol-Related Hepatitis Improves Clinical Outcomes and Modulates Regenerative-Immune Pathways: A Randomized Study (Abstract ID: 179) |
||||||
|
10:20 - 10:30 |
A population based epidemiological study of Inflammatory Bowel Disease in India(Abstract ID: 403) |
||||||
|
10:30 - 10:40 |
Efficacy and Safety of Magnetic Compression Anastomosis in Complex Biliary Strictures: A Prospective Multicentre Clinical Study with Short and Long Term Outcomes
(Abstract ID: 518) |
||||||
|
10:40 - 10:50 |
Endoscopic ultrasound-guided coil and glue embolization versus balloon-occluded retrograde transvenous obliteration for prevention of rebleeding from gastric varices: A multicentre, randomized controlled trial (Abstract ID: 864) |
||||||
|
10:50 - 11:00 |
Mapping Microbial Diversity Across Endogamous India: The Indian Human Microbiome Initiative (Abstract ID: 977) |
||||||
|
11:00 - 11:30 |
Nutrition Break |
||||||
|
11:30 - 12:30 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
11:30 - 11:45 |
Esophageal
Disorders |
Cerebral Edema And
Intracranial Pressure Monitoring in ALF |
EUS Guided Biliary Drainage
|
The AI Gastroenterologist: A Chimera or the New Normal in
the Evolving Era of Digestive Healthcare |
Pediatric Acute Pancreatitis:
Special Challenges |
||
|
11:45 - 12:00 |
Gastroduodenal
Disorders |
Infections in ALF:
Assessment, Prevention, Management |
Disconnected Pancreatic Duct
Syndrome: Diagnosis to Therapy |
Beyond the Buzzwords:
Where AI Is Already Changing GI Practice |
Drug-Induced Pancreatitis:
Truth or myth |
||
|
12:00 - 12:15 |
Bowel And Anorectal Disorders
|
Novel Strategies To Improve
Outcomes in ALF |
Ampullectomy: Tricks of the
Trade |
Artificial Inteligence in
Endoscopy: Current Evidence, Clinical Utility and Implementation Pathways |
Chronic Pancreatitis and Type
3c Diabetes: Mechanisms and Special Considerations For Management |
||
|
12:15 - 12:30 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
12:30 - 13:30 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
12:30 - 12:45 |
Early-Onset Colorectal
Cancer: An Emerging Global Concern |
ACLF Endotypes and
Trajectories: Toward Global Harmonization and Precision Trials |
POEM and GERD: New Evidence
and Evolving Concepts |
Trust, Risk, and Regulation:
How to Approve AI For Real Patients |
Timing of Cholecystectomy in
Severe Acute Pancreatitis |
||
|
12:45 - 13:00 |
Upper GI Cancer Screening and
Early Detection: Lessons from India |
Ammonia As a Biomarker in
Cirrhosis and ACLF |
G-POEM: Selecting The Right
Responders |
AI in Endoscopy Training:
Promises and Threats, AI in Endoscopy Training |
Early Diagnosis And
Biomarkers Of Gallbladder Cancer |
||
|
13:00 - 13:15 |
Third-Space Endoscopy: East
Meets West |
Advances in Extracorporeal
Liver Systems For ACLF |
Robotic Endoscopy: Are We
Ready for Prime Time? |
AI in Hepatology -
Revolutionizing The Diagnosis and Management |
Incidental Gallbladder Cancer
After Cholecystectomy: Approach To Management |
||
|
13:15 - 13:30 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
13:30 - 14:45 |
Lunch and Poster Viewing |
||||||
|
Session: |
Endoscopic |
Industry
Lunch |
Lunch Session |
Lunch Session |
Lunch Session |
||
|
14:45 - 16:00 |
Session: |
Session: |
Endoscopic |
Session |
Session: |
Session: |
Session: |
|
14:45 - 15:00 |
Introductions |
Recent Advances In The
Endovascular Management of HCC |
|||||
|
15:00 - 15:15 |
CCFI Oration -
IBD |
Prophylactic and Pre-Emptive
TIPS: Overtreatment or Survival Advantage? |
|||||
|
15:15 - 15:30 |
INMA Oration |
Vascular Emergencies in
Cirrhosis – Role of IR |
|||||
|
15:30 - 15:45 |
WGO - Trailblazer
Award |
Q&A |
|||||
|
15:45 - 16:00 |
Masters of WGO
|
||||||
|
16:00 - 17:00 |
Closing Ceremonies |
||||||
|
17:00 |
Adjourn |
||||||
©Copyright WCOG 2026 India. All Rights Reserved